Indication
Psychotropic Drugs
2 clinical trials
3 products
Clinical trial
A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderStatus: Completed, Estimated PCD: 2022-09-23
Product
LY03010Clinical trial
A Study to Evaluate the PK Profiles of LY03010 and Relative Bioavailability at Steady-state of LY03010 Versus INVEGA SUSTENNA in Schizophrenia PatientsStatus: Completed, Estimated PCD: 2022-03-15
Product
Paliperidone palmitateProduct
Invega Sustenna